NCT04178187View on ClinicalTrials.gov

The Role of Probiotics in the Eradication of Helicobacter Pylori

NACompletedINTERVENTIONAL
Enrollment

660

Participants

Timeline

Start Date

October 2, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Caps Lactolevure

One group will receive Caps Lactolevure x2 and the other group Caps Placebo x2.

DRUG

Caps Placebo

Caps Placebo

Trial Locations (5)

10676

Evangelismos Hospital, Athens

11521

NIMTS Hospital, Athens

17562

Iatriko Palaiou Falirou, Palaió Fáliro

54636

University General Hospital of Thessaloniki AHEPA, Thessaloniki

54642

General Hospital of Thessaloniki Ippokratio, Thessaloniki

All Listed Sponsors
lead

Evangelismos Hospital

OTHER

NCT04178187 - The Role of Probiotics in the Eradication of Helicobacter Pylori | Biotech Hunter | Biotech Hunter